e-Drug3D 631 |
cas 79902-63-9 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters F 5 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMG-COA) |
DrugCentral 3-hydroxy-3-methylglutaryl-coenzyme A reductase UNIPROT P04035 HMGCR |
Download SDF file | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate Formula: Calculated chemical properties: MW 418.55 NB_atoms 30 XLogP 4.59 PSA 65.437 NB_HD 1 NB_HA 5 fsp3 0.76 Lipinski(0=no;1=yes) 1 |
FDA NDA 019766 (label) INN (SIMVASTATIN) ZOCOR (ORGANON) APPROVAL= AP YEAR= 1991 NDA 021687 (label) INN (EZETIMIBE ; SIMVASTATIN) VYTORIN (ORGANON) APPROVAL= AP YEAR= 2004 NDA 076532 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (TEVA PHARMS) APPROVAL= TA YEAR= 2005 NDA 076052 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (IVAX SUB TEVA PHARMS) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 076285 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (SUN PHARM INDS LTD) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 076685 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (WATSON LABS TEVA) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 077691 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2006 NDA 077752 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (GRAVITI PHARMS) APPROVAL= AP YEAR= 2006 NDA 077766 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (CHARTWELL RX) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 077837 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (ZYDUS PHARMS USA) APPROVAL= AP YEAR= 2006 NDA 078034 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (BIOCON PHARMA) APPROVAL= AP YEAR= 2006 NDA 021961 (label) INN (SIMVASTATIN) SIMVASTATIN (SYNTHON PHARMS) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 078103 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (LUPIN) APPROVAL= AP YEAR= 2007 NDA 078425 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (DR REDDYS LABS LTD) APPROVAL= AP YEAR= 2007 OBSOLETE NDA 022078 (label) INN (SIMVASTATIN) SIMCOR (ABBVIE) APPROVAL= AP YEAR= 2008 OBSOLETE NDA 078155 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2008 NDA 078735 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (OXFORD PHARMS) APPROVAL= AP YEAR= 2010 NDA 090868 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (PHARMOBEDIENT) APPROVAL= AP YEAR= 2010 DISCONTINUED NDA 090383 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (MICRO LABS) APPROVAL= AP YEAR= 2011 NDA 202343 (label) INN (SIMVASTATIN ; SITAGLIPTIN PHOSPHATE) JUVISYNC (MERCK SHARP DOHME) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 200895 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (HETERO LABS LTD III) APPROVAL= AP YEAR= 2014 NDA 206679 (label) INN (SIMVASTATIN) FLOLIPID (SALERNO PHARMS) APPROVAL= AP YEAR= 2016 NDA 201890 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (ANI PHARMS) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 200909 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2017 NDA 202968 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (WATSON LABS INC) APPROVAL= AP YEAR= 2017 NDA 206557 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (INVAGEN PHARMS) APPROVAL= AP YEAR= 2017 NDA 208831 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (AMNEAL PHARMS CO) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 209222 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (ALKEM LABS LTD) APPROVAL= AP YEAR= 2017 NDA 208699 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2019 NDA 200082 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (AUROBINDO PHARMA USA) APPROVAL= AP YEAR= 2020 NDA 211394 (pdf not found) INN (SIMVASTATIN) SIMVASTATIN (YILING) APPROVAL= AP YEAR= 2024 NDA 211663 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (SCIEGEN PHARMS INC) APPROVAL= AP YEAR= 2024 DISCONTINUED NDA 209461 (pdf not found) INN (EZETIMIBE ; SIMVASTATIN) EZETIMIBE AND SIMVASTATIN (TORRENT) APPROVAL= AP YEAR= 2025 DISCONTINUED |
Other links: |